Sign In

Drew Holzapfel

Managing Partner at High Lantern Group

Professional Background

Drew Holzapfel is a seasoned expert in the intersection of healthcare communications and public affairs, with a wealth of experience across various sectors in the pharmaceutical industry and beyond. Currently, he serves as the Managing Partner at High Lantern Group, where he leads a talented team in providing strategic counsel to clients in the healthcare space. With a deep commitment to addressing critical healthcare challenges, Drew has navigated the complexities of the industry by fostering impactful dialogues among patients, healthcare providers, and policymakers. His role at High Lantern Group highlights his expertise in market access, stakeholder engagement, and advocacy, making him a sought-after consultant in both the public and private sectors.

Before ascending to his current position, Drew's career was marked by significant roles at renowned organizations, including his tenure at Pfizer, where he had multiple responsibilities. He was pivotal in global commercial development, enhancing the company's ability to engage with key opinion leaders in the medical field. His contributions in public affairs, especially within the specialty pharmaceutical business unit, positioned him as a valuable asset to Pfizer’s mission of improving patient care through innovative solutions.

In addition to his corporate achievements, Drew is also recognized for his commitment to advancing Alzheimer’s research and advocacy. He previously served as a Founding Board Member at the Global Alzheimer's Platform Foundation and has been an active Board Member at USAgainstAlzheimer's. This involvement illustrates his passion for addressing one of the most pressing health challenges of our time, as he has worked tirelessly to influence policies that enhance funding and support for Alzheimer’s research.

Education and Achievements

Drew's academic foundation has been instrumental in shaping his professional journey. He holds a Bachelor of Arts in Political Science, focusing on Human and Natural Ecology from Emory University. This educational background provided him with a robust understanding of the political landscape surrounding healthcare issues and the interplay between human health and the environment. Drew continued his education at the University of Maryland's Robert H. Smith School of Business, where he earned an MBA in Marketing. His MBA studies not only honed his business acumen but also enhanced his strategic thinking abilities—qualities that he applies in his current leadership role.

Drew's early education at Indian Hill High School set the stage for his diverse career, equipping him with essential skills that would serve him well in both academia and the professional world.

Notable Achievements

Drew Holzapfel’s career is marked by numerous accomplishments that highlight his expertise and dedication. His leadership roles at High Lantern Group have resulted in successful campaigns that have significantly impacted public perception and understanding of health issues. Additionally, his work at Pfizer and other healthcare organizations has allowed him to play a crucial role in formulating strategies that effectively engage healthcare providers and the public.

Drew's strategic insights in stakeholder engagement have been recognized in various publications and conferences, where he often shares his expertise on healthcare communication and advocacy. His contributions extend beyond mere organizational roles; they signify a larger commitment to transforming the healthcare landscape for the better.

Overall, Drew Holzapfel’s professional journey reflects a meaningful blend of education, expertise, and social impact, positioning him as a leader in healthcare communication and advocacy. His multifaceted career illustrates a commitment to not only advancing business goals but also addressing the critical health concerns that affect populations across the globe.

Related Questions

How did Drew Holzapfel transition from his initial roles in public service to leadership in healthcare communications?
What insights has Drew Holzapfel gained from his experience at Pfizer that influence his current role at High Lantern Group?
In what ways has Drew Holzapfel contributed to the advancement of Alzheimer’s research and advocacy during his time on various boards?
How does Drew Holzapfel's educational background in political science and marketing inform his approach to healthcare strategy?
What strategies does Drew Holzapfel believe are critical in fostering effective communication between pharmaceutical companies and patients?
Drew Holzapfel
Add to my network

Location

Greater Philadelphia